Cerbios Pharma SA showcasing new nanoparticle technology at CPhI Worldwide

Cerbios Pharma SA showcasing new nanoparticle technology at CPhI Worldwide


Press Release | Cerbios-Pharma SA

OCTOBER 05, 2017

Lugano, Switzerland: – Cerbios Pharma SA, a Swiss-based high-tech CDMO, will highlight its super critical fluid (SCF) technology during the CPhI Worldwide pharmaceutical fair in Frankfurt (Booth 6.1 B52).

Cerbios Pharma cGMP atomization particle engineering plant, based on SCF technology is able to generate micro and nano APIs particles with very narrow and controlled particle size distribution. Along with SCF, Cerbios Pharma will also present its full range of manufacturing capabilities, from small to large molecules, including Highly Potent Active Pharmaceutical Ingredients (HPAIs), recombinant proteins and monoclonal antibodies, antibody drug conjugates (ADCs) and GMP probiotics.

Return to Frankfurt

The Cerbios-Pharma team at CPhI Worldwide will include CEO Gabriel Haering, members of its M&S team and purchasing departments.

“Cerbios is very pleased to return to Frankfurt, where we began our association with this amazing event in 1999,” said Mr. Haering.

Cerbios will exhibit as part of the “Piazza Ticino” zone at Messe Frankfurt, dedicated to highlight the achievements of the Switzerland Italian canton that has become a worldwide pharmaceutical excellence center.

Enhanced HPAIs

Opened in 2015, the Cerbios atomization plant is now fully operational for the handling of HPAIs (High Potency Active Ingredients) under cGMP.

The Cerbios plant supports two different atomization technologies, providing a wide array of options to achieve unique particle features, including particle size distribution and specific surface area as well as superior formulation performance.

Nanonization enhances some properties of the APIs, including potency, solubility and permeability, boosting up the in-vivo activity of the API.

Such improvements potentially allow active compounds to obtain the same therapeutic effects with lower dosage, resulting in significant benefits to the patients, in terms of side effects and tolerability.

The nanoparticle technology is further expanding the Cerbios contract manufacturing services platform in the area of small molecules HPAIs

About Cerbios

Cerbios-Pharma SA (Cerbios) is a privately held company located in Lugano, Switzerland that has built up leading-edge expertise in development and production of small molecule chemical and biological active pharmaceutical ingredients (APIs for partners worldwide.

Its Chemical Division offers exclusive, third party manufacturing services for High Potency Active Ingredients (HPAIs), while the Biological Division specializes in monoclonal antibodies, recombinant proteins, antibody drug conjugates (ADCs) and GMP grade probiotics.

Cerbios provides full CMC support to its worldwide partners, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs. Paramount to this is the ability to supply all of the technical documentation and support necessary for a successful registration. Cerbios’ commercial products are marketed worldwide but primarily in Europe, USA and Japan.

About CPhI Worldwide 2017
CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors networking opportunities with potential international pharmaceutical partners and collaborators, as well as latest industry insights.

Now in its 28th year, CPhI 2017 is a three-day event opening October 24 at the Messe Frankfurt exhibition center. Last year’s event in Barcelona attracted some 42,000 delegates and more than 2,500 exhibitor companies from 155 countries worldwide.

CPhI Worldwide is held alongside four other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment, InnoPack pharmaceutical packaging and a new addition, the FDF show for Finish, Dosage and Formulations, bringing together every aspect of the finished dosage supply chain.

The CPhI Pharma Awards, presented on the first evening of the conference, honor innovative companies and leaders.

The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: http://www.cphi.com/europe/.

Media Contact

Simone Sala, Business Development BD Manager, Cerbios-Pharma SA
Email: simone.sala@cerbios.ch
Tel: +41 91 9856556


Click on Cerbios Pharma showcasing nanoparticle technology at CPhI Worldwide for more information.
Click on Cerbios-Pharma to contact the company directly.

Supplier Information
Supplier: Cerbios-Pharma SA
Address: Via Figino 6, 6917 Barbengo/Lugano Switzerland
Tel: +41 (0) 919856311
Fax: +41 (0) 919856325
Website: www.cerbios.ch

Comments are closed.